Islet Holdings Inc
OTC:ISHI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (0), the stock would be worth $0 (23% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.1 | $0 |
0%
|
| 3-Year Average | 0 | $0 |
-23%
|
| 5-Year Average | 0 | $0 |
-23%
|
| Industry Average | 28.3 | $0.05 |
+51 344%
|
| Country Average | 23.2 | $0.04 |
+42 085%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
I
|
Islet Holdings Inc
OTC:ISHI
|
20.6k USD | 0.1 | -0 | |
| JP |
|
Paris Miki Holdings Inc
TSE:7455
|
58T JPY | 44.8 | 27.7 | |
| CN |
|
Pop Mart International Group Ltd
HKEX:9992
|
211.1B HKD | 20.3 | 14.7 | |
| US |
|
Ulta Beauty Inc
NASDAQ:ULTA
|
23.7B USD | 21.3 | 20.4 | |
| US |
|
DICK'S Sporting Goods Inc
NYSE:DKS
|
20.2B USD | 51.3 | 23.8 | |
| CN |
|
China Tourism Group Duty Free Corp Ltd
SSE:601888
|
135.8B CNY | 21.6 | 37.9 | |
| US |
|
Tractor Supply Co
NASDAQ:TSCO
|
18.5B USD | 35.7 | 16.5 | |
| HK |
|
Chow Tai Fook Jewellery Group Ltd
HKEX:1929
|
104.9B HKD | 21.3 | 17.9 | |
| US |
|
Five Below Inc
NASDAQ:FIVE
|
13B USD | 29 | 35.8 | |
| NL |
G
|
Grandvision NV
F:8GV
|
7.2B EUR | 11.1 | 20.1 | |
| JP |
|
Sanrio Co Ltd
TSE:8136
|
1.1T JPY | 22.1 | 21.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.4 |
| Median | 23.2 |
| 70th Percentile | 35.1 |
| Max | 3 178 983.5 |
Other Multiples
Islet Holdings Inc
Glance View
Islet Holdings Inc. engages in the research, development, and commercialization of patented technologies in the field of transplantation therapy for people with conditions of insulin-dependent diabetes. The company is headquartered in Salt Lake City, Utah and currently employs 7 full-time employees. The firm is engaged in the research, development and commercialization of patented technologies in the field of transplantation in the therapy of people with conditions of insulin-dependent diabetes. The firm is developing intellectual property relating to hemp farming and extraction of cannabidiol (CBD) from hemp. Its technology constitutes methods for isolating, culturing, cryopreservation and immune-protection (microencapsulation) of islet cells. The firm's product candidates are intended for the treatment of insulin-dependent diabetes and are intended to be administered into the patient's abdominal cavity, where the transplanted islet cells will produce insulin in response to increase in blood glucose. The primary function of microencapsulation is to protect the islets from the host's immune system. The microcapsule coating is composed of layers of biocompatible materials.
